May 4 (Reuters) - Westpac Banking Corp (WBC) :
- WELL CAPITALISED & LIQUIDITY AND FUNDING METRICS ARE COMFORTABLY ABOVE REGULATORY REQUIREMENTS
- FUNDING AND LIQUIDITY STRENGTHENED OVER HALF AS CUSTOMER DEPOSITS GREW FASTER THAN LOANS
- HOUSE PRICES EXPECTED TO FALL THROUGH REMAINDER OF 2020
- ACCEPTED APRA'S CONSISTENT GUIDANCE ON DIVIDENDS & BEING PRUDENT AT THIS POINT IN TIME
- WILL CONTINUE TO ASSESS OPPORTUNITIES TO IMPROVE CAPITAL UTILISATION ACROSS GROUP
- SUSTAINED RECOVERY OF AUSTRALIAN ECONOMY CANNOT BE EXPECTED UNTIL DEC QUARTER , BUT EXPECTS CAUTION TO PREVAIL INTO 2021
- AUSTRALIA STILL FACES A SHARP ECONOMIC CONTRACTION IN 2020 WITH SOLID REBOUND NOT EXPECTED UNTIL DECEMBER QUARTER
- AUSTRALIA'S EXPORTS TO LIKELY BENEFIT FROM RECOVERY IN CHINESE ECONOMY
Source: https://bit.ly/2ynrD1e
(([email protected];))
- Forums
- ASX - By Stock
- WBC
- News: WBC Westpac Says Sustained Recovery Of Australian Economy Cannot Be Expected Until Dec...
WBC
westpac banking corporation
Add to My Watchlist
1.94%
!
$33.90

News: WBC Westpac Says Sustained Recovery Of Australian Economy Cannot Be Expected Until Dec...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$33.90 |
Change
-0.670(1.94%) |
Mkt cap ! $116.0B |
Open | High | Low | Value | Volume |
$34.70 | $34.85 | $33.90 | $153.5M | 4.497M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8265 | $33.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$33.92 | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 885 | 33.850 |
2 | 5090 | 33.800 |
1 | 3415 | 33.730 |
1 | 29 | 33.710 |
1 | 220 | 33.670 |
Price($) | Vol. | No. |
---|---|---|
33.980 | 29 | 1 |
34.030 | 2461 | 1 |
34.070 | 8000 | 1 |
34.100 | 2300 | 2 |
34.140 | 6641 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
WBC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online